Next Article in Journal
Generic Medicine Pricing Policies in Europe: Current Status and Impact
Next Article in Special Issue
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
Previous Article in Journal
Degradation of Methyldopa by Banana
Previous Article in Special Issue
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain

Cell-Penetrating Peptides for Antiviral Drug Development

School of Public Health, University of California, Berkeley, CA 94720, USA
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(3), 448-470;
Received: 24 December 2009 / Revised: 6 February 2010 / Accepted: 1 March 2010 / Published: 2 March 2010
(This article belongs to the Special Issue Cell-penetrating Peptides 2012)
Viral diseases affect hundreds of millions of people worldwide, and the few available drugs to treat these diseases often come with limitations. The key obstacle to the development of new antiviral agents is their delivery into infected cells in vivo. Cell-penetrating peptides (CPPs) are short peptides that can cross the cellular lipid bilayer with the remarkable capability to shuttle conjugated cargoes into cells. CPPs have been successfully utilized to enhance the cellular uptake and intracellular trafficking of antiviral molecules, and thereby increase the inhibitory activity of potential antiviral proteins and oligonucleotide analogues, both in cultured cells and in animal models. This review will address the notable findings of these studies, highlighting some promising results and discussing the challenges CPP technology has to overcome for further clinical applications. View Full-Text
Keywords: cell-penetrating peptide; antivirals; antisense; drug delivery cell-penetrating peptide; antivirals; antisense; drug delivery
Show Figures

Figure 1

MDPI and ACS Style

Delcroix, M.; Riley, L.W. Cell-Penetrating Peptides for Antiviral Drug Development. Pharmaceuticals 2010, 3, 448-470.

AMA Style

Delcroix M, Riley LW. Cell-Penetrating Peptides for Antiviral Drug Development. Pharmaceuticals. 2010; 3(3):448-470.

Chicago/Turabian Style

Delcroix, Melaine, and Lee W. Riley. 2010. "Cell-Penetrating Peptides for Antiviral Drug Development" Pharmaceuticals 3, no. 3: 448-470.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop